Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Change in Acquisitions & Divestments (2016 - 2018)

Historic Change in Acquisitions & Divestments for Palisade Bio (PALI) over the last 4 years, with Q1 2018 value amounting to $5.0 million.

  • Palisade Bio's Change in Acquisitions & Divestments changed N/A to $5.0 million in Q1 2018 from the same period last year, while for Dec 2018 it was $5.0 million, marking a year-over-year change of. This contributed to the annual value of $5.0 million for FY2018, which is 0.0% changed from last year.
  • Palisade Bio's Change in Acquisitions & Divestments amounted to $5.0 million in Q1 2018.
  • Palisade Bio's 5-year Change in Acquisitions & Divestments high stood at $15.0 million for Q1 2015, and its period low was $5.0 million during Q1 2018.
  • In the last 4 years, Palisade Bio's Change in Acquisitions & Divestments had a median value of $8.8 million in 2014 and averaged $9.4 million.
  • Within the past 5 years, the most significant YoY rise in Palisade Bio's Change in Acquisitions & Divestments was 4990.86% (2016), while the steepest drop was 4990.86% (2016).
  • Palisade Bio's Change in Acquisitions & Divestments (Quarter) stood at $10.0 million in 2014, then soared by 50.07% to $15.0 million in 2015, then tumbled by 49.91% to $7.5 million in 2016, then tumbled by 33.49% to $5.0 million in 2018.
  • Its last three reported values are $5.0 million in Q1 2018, $7.5 million for Q1 2016, and $15.0 million during Q1 2015.